Pegasta 6 Mg Prefilled Syringe 0.6 Ml is a medicine used to reduce the risk of severe infection in cancer patients receiving chemotherapy. Chemotherapy can lower the body's white blood cell count, leaving patients vulnerable to serious bacterial infections, and this medicine helps boost cell production.
It contains pegfilgrastim, a leukocyte growth factor. It works by stimulating the bone marrow to produce new white blood cells (neutrophils) that fight infection. It is administered as an injection under the skin (subcutaneously) by or under the guidance of a healthcare professional, usually 24 hours after a chemotherapy dose.
To support your immune health during treatment, practice good hand hygiene, avoid close contact with individuals who have active infections, and follow all dietary and sanitary guidelines provided by your oncology team.
Before receiving this medicine, inform your doctor if you have sickle cell anaemia, kidney conditions, or a history of lung disease. Report any unexpected fever, chills, severe bone pain, or left upper stomach pain to your care team immediately. Consult your doctor if you are pregnant or breastfeeding.














































